Traphaco JSC
VN:TRA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
72 907.5086
85 300
|
| Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Traphaco JSC
Accounts Receivables
Traphaco JSC
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Traphaco JSC
VN:TRA
|
Accounts Receivables
₫257.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
2%
|
|
|
H
|
HaTay Pharmaceutical JSC
VN:DHT
|
Accounts Receivables
₫110.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
7%
|
|
|
I
|
Imexpharm Corp
VN:IMP
|
Accounts Receivables
₫357.3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
|
C
|
Cuu Long Pharmaceutical JSC
VN:DCL
|
Accounts Receivables
₫266.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
D
|
Domesco Medical Import Export Joint Stock Corp
VN:DMC
|
Accounts Receivables
₫706.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
9%
|
|
|
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
Accounts Receivables
₫446.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
Traphaco JSC
Glance View
Traphaco JSC engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Hanoi, Hanoi and currently employs 1,476 full-time employees. The company went IPO on 2008-11-26. The firm manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. The company is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry. Other activities of the Company include manufacturing and trading beer, wine and soft drinks (excluding bar business). As of December 31, 2012, the Company had three subsidiaries operating in the similar industry. As of the same date, it had 14 branches.
See Also
What is Traphaco JSC's Accounts Receivables?
Accounts Receivables
257.7B
VND
Based on the financial report for Jun 30, 2024, Traphaco JSC's Accounts Receivables amounts to 257.7B VND.
What is Traphaco JSC's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
2%
Over the last year, the Accounts Receivables growth was 37%. The average annual Accounts Receivables growth rates for Traphaco JSC have been 13% over the past three years , 13% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
